Blood pressure variability, dementia, and role of antihypertensive medications in older adults
- 1 July 2023
- journal article
- research article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (7), 2966-2974
- https://doi.org/10.1002/alz.12935
Abstract
IntroductionWe assessed the association between visit-to-visit blood pressure variability (BPV) up to 12 years and subsequent dementia risk, and tested the modifying effect of antihypertensive medications. MethodsWe studied 2234 participants from two community-based cohorts of older adults with normal cognition or mild cognitive impairment. Participants were followed through annual assessments for up to 27 years. Visit-to-visit BPV was quantified over 3, 6, 9, and 12 years, respectively. ResultsHigher systolic BPV (SBPV) during 3, 6, 9, and 12 years was associated with a subsequent increased risk of dementia, with hazard ratios ranging from 1.02 (95% confidence interval [CI]: 1.01-1.04) to 1.10 (95% CI: 1.05-1.16). The association between SBPV and dementia risk was stronger among participants not taking calcium channel blockers (p-for interaction < 0.05). DiscussionAmong older adults, long-term exposure to higher visit-to-visit SBPV is associated with an increased risk of dementia later in life, and calcium channel blockers may modify this association. HighlightsAmong adults aged >65, higher systolic blood pressure variability spanning 3-12 years is associated with an increased risk of dementia later in life.Single blood pressure measurement or mean blood pressure levels does not seem to associate with dementia risk among older adults.The association between systolic blood pressure variability and dementia risk is stronger among those not taking calcium channel blocker medications.Funding Information
- National Institute on Aging (P30AG10161, P30AG72975, R01AG15819, R01AG17917)
This publication has 31 references indexed in Scilit:
- ipw: AnRPackage for Inverse Probability WeightingJournal of Statistical Software, 2011
- Effects of β blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of strokeThe Lancet Neurology, 2010
- Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertensionThe Lancet, 2010
- Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysisThe Lancet, 2010
- Association of Muscle Strength With the Risk of Alzheimer Disease and the Rate of Cognitive Decline in Community-Dwelling Older PersonsArchives of Neurology, 2009
- Statins, incident Alzheimer disease, change in cognitive function, and neuropathologyNeurology, 2008
- The Relation of Cigarette Smoking to Incident Alzheimer’s Disease in a Biracial Urban Community PopulationNeuroepidemiology, 2006
- Relation of Blood Pressure to Risk of Incident Alzheimer’s Disease and Change in Global Cognitive Function in Older PersonsNeuroepidemiology, 2005
- Blood Pressure, Systolic and Diastolic, and Cardiovascular RisksArchives of Internal Medicine, 1993
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984